Adapting prime editing with split prime editors in Escherichia coli and its application to Staphylococcus aureus genome editing
Applied Microbiology and Biotechnology · 04.06.2026 · 110 (1)
DOI: 10.1007/s00253-026-13897-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 04.06.2026. Verfasst von Seong Hyeok Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. Hauptthemen laut MEDLINE: Escherichia coli, Gene Editing, Methicillin-Resistant Staphylococcus aureus, Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prime editing is a precise and rapid genome-editing technique that modifies short DNA sequences using tailored guide RNAs. To implement this technique in bacteria, we used Prime Editor 2 (PE2) with the DeepPrime gRNA design tool and assessed its gene-editing efficiency in Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA) cells. Our findings indicate that a split PE2, comprising a reverse transcriptase and two Cas9 nickase domains, exhibited gene-editing efficiency comparable to that of the intact PE2. The efficiency observed in E. coli was significantly affected by the target sites, edit type, and the presence of exonucleases. In MRSA, which serves as a model to evaluate the applicability in non-model bacterial species, Streptococcus pyogenes PE2 (SpPE2) exhibited superior performance relative to Staphylococcus aureus PE2 (SaPE2). Furthermore, the split SpPE2 lacking the reverse transcriptase successfully induced the intended mutation in MRSA. This study demonstrates the feasibility of prime editing within bacterial systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Institute of Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Department of Pharmacology, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
- Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. choleo@yuhs.ac.
- Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. choleo@yuhs.ac.
Zitieren
APA
Ma, S. H., Yu, G., Park, S., Sung, H., Jeong, U. J., Kim, H. H., Cho, J., & Yoon, S. S. (2026). Adapting prime editing with split prime editors in Escherichia coli and its application to Staphylococcus aureus genome editing. Applied Microbiology and Biotechnology, 110(1). https://doi.org/10.1007/s00253-026-13897-9
Vancouver
Ma SH, Yu G, Park S, Sung H, Jeong UJ, Kim HH, et al. Adapting prime editing with split prime editors in Escherichia coli and its application to Staphylococcus aureus genome editing. Applied Microbiology and Biotechnology. 2026;110(1). doi:10.1007/s00253-026-13897-9
BibTeX
@article{Ma2026,
author = {Ma, Seong Hyeok and Yu, Goosang and Park, Suyeon and Sung, Hyuna and Jeong, Uk Jin and Kim, Hyongbum Henry and Cho, Junho and Yoon, Sang Sun},
title = {Adapting prime editing with split prime editors in Escherichia coli and its application to Staphylococcus aureus genome editing},
journal = {Applied Microbiology and Biotechnology},
year = {2026},
volume = {110},
number = {1},
doi = {10.1007/s00253-026-13897-9}
}
EUVIMED